Stages I-III Liver Cancer


Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the... Continue Reading

Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors... Continue Reading

CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver... Continue Reading

Nexavar Superior to Sutent in Liver Cancer (June 23, 2011)

Nexavar® (sorafenib) provides superior overall survival to Sutent® (sunitinib) in the treatment of hepatocellular (liver) cancer. These results were presented at the 2011 annual American Society of Clinical... Continue Reading

Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)

According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better survival... Continue Reading

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were... Continue Reading

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma (February 3, 2009)

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma According to the results of a Phase II clinical trial, the combination of two targeted therapies-Avastin® (bevacizumab) and... Continue Reading

Nexavar® Effective for Hepatocellular Carcinoma in Asians (January 21, 2009)

Nexavar® Effective for Hepatocellular Carcinoma in Asians Researchers from 23 medical centers in Asia have reported that Nexavar® (sorafenib) is effective in patients with advanced hepatocellular carcinoma... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer (April 4, 2008)

Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in liver cancer difficult to... Continue Reading

Updates on the Management of Advanced Hepato-pancreato-biliary Malignancies (October 21, 2007)

Updates on the Management of Advanced Hepato-pancreato-biliary Malignancies: A Report from the 14th European Cancer Conference (ECCO) Introduction The 14th European Cancer Conference of the European Cancer... Continue Reading

Addition of Nexavar® to Adriamycin® Improves Survival in Hepatocellular Carcinoma (October 1, 2007)

Addition of Nexavar® to Adriamycin® Improves Survival in Hepatocellular Carcinoma According to results recently presented at the 2007 European Cancer Organization (ECCO 14), the addition of the targeted... Continue Reading

Higher Hospital Volume Linked with Better Survival After Gastrointestinal Surgery (November 8, 2006)

Higher Hospital Volume Linked with Better Survival After Gastrointestinal Surgery According to the results of a study conducted in Taiwan, patients with stomach, liver, colorectal, or esophageal cancers... Continue Reading

Sustained Response to TACE Linked with Lower Recurrence Risk after Liver Transplantation (August 10, 2006)

Sustained Response to TACE Linked with Lower Recurrence Risk after Liver Transplantation Among liver cancer patients who are potential candidates for liver transplantation, those who experience a sustained... Continue Reading

Good Results After Liver Transplantation for Childhood Liver Cancer (February 7, 2006)

Good Results After Liver Transplantation for Childhood Liver Cancer According to a study published in the Journal of Pediatric Surgery, children who undergo liver transplantation for the treatment of inoperable... Continue Reading

Photodynamic Therapy Improves Survival with Bile Duct Cancer (October 19, 2005)

Photodynamic Therapy Improves Survival with Bile Duct Cancer According to a study published in the American Journal of Gastroenterology, treatment of nonresectable bile duct cancer with photodynamic therapy... Continue Reading

Better Outcomes with Liver Transplant for Hilar Cholangiocarcinoma Patients (September 14, 2005)

Better Outcomes with Liver Transplant for Hilar Cholangiocarcinoma Patients For patients with localized, node-negative hilar cholangiocarcinoma, liver transplantation preceded by radiation and chemotherapy... Continue Reading

Carboplatin/Epinephrine Injections Directly into Cancer Effective for Liver Cancer (February 28, 2003)

Carboplatin/Epinephrine Injections Directly into Cancer Effective for Liver Cancer According to a recent article published in the Journal of Clinical Oncology, injections of carboplatin and epinephrine... Continue Reading

Radiofrequency Ablation Reduces Local Recurrences Compared to Cryosurgery for Treatment of Inoperable Liver Cancer or Metastasis to the Liver (January 9, 2003)

Radiofrequency Ablation Reduces Local Recurrences Compared to Cryosurgery for Treatment of Inoperable Liver Cancer or Metastasis to the Liver According to a recent article published in the Archives... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS